韦扬通格鲁粒通过PPARγ/NF-κB/CDX2信号通路减轻胃肠道代谢

Yimin Liang1,2, Shijie Su1,2,3,4, Ting Jin1,2

  • 1The First Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.

Chinese medicine
|March 3, 2026
PubMed
概括

扬通颗粒 (WYTLG) 在治疗胃肠转化症 (GIM),一种癌前疾病方面表现有前途. 这种传统中医药配方通过调节PPARγ/NF-κB/CDX2通路而起作用,为胃癌预防提供了潜在的策略.